On the behavioral economics of medication choice: A research story.
Document Type
Article
Publication Date
8-2019
Identifier
DOI: 10.1016/j.beproc.2019.05.019
Abstract
Behavioral economics has been consistently useful in describing a wide range of clinical phenomena, particularly in reference to behavioral excesses such as substance abuse, problematic gambling and obesity/overeating. Given an opportunity to explore these processes as they relate to treatment adherence in patients with multiple sclerosis (MS), our central thesis was that behavioral economic tools/processes that have been helpful in other areas of application (e.g., substance abuse, obesity) could be leveraged to help understand treatment non-adherence and hopefully lead to efforts to combat it. The current paper tells a story of how an interdisciplinary set of researchers came to combine their separate expertise in MS and behavioral economics to yield novel insights into the failures of treatment adherence often experienced in this clinical population.
Journal Title
Behavioural processes
Volume
165
First Page
66
Last Page
77
MeSH Keywords
Adult; Antirheumatic Agents; Choice Behavior; Counseling; Economics, Behavioral; Female; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Male; Medication Adherence; Multiple Sclerosis; Research; Substance-Related Disorders; Telephone; Treatment Outcome
Keywords
Adherence; Modeling; Multiple sclerosis; Probability discounting
Recommended Citation
Jarmolowicz DP, Reed DD, Bruce AS, Bruce JM. On the behavioral economics of medication choice: A research story. Behav Processes. 2019;165:66-77. doi:10.1016/j.beproc.2019.05.019